204 related articles for article (PubMed ID: 32733384)
1. Systems Analysis of Insulin and IGF1 Receptors Networks in Breast Cancer Cells Identifies Commonalities and Divergences in Expression Patterns.
Sarfstein R; Yeheskel A; Sinai-Livne T; Pasmanik-Chor M; Werner H
Front Endocrinol (Lausanne); 2020; 11():435. PubMed ID: 32733384
[TBL] [Abstract][Full Text] [Related]
2. Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells.
Sarfstein R; Nagaraj K; LeRoith D; Werner H
Cells; 2019 Nov; 8(12):. PubMed ID: 31771180
[TBL] [Abstract][Full Text] [Related]
3. Both IGF1R and INSR Knockdown Exert Antitumorigenic Effects in Prostate Cancer In Vitro and In Vivo.
Ofer P; Heidegger I; Eder IE; Schöpf B; Neuwirt H; Geley S; Klocker H; Massoner P
Mol Endocrinol; 2015 Dec; 29(12):1694-707. PubMed ID: 26452103
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis.
Heidegger I; Kern J; Ofer P; Klocker H; Massoner P
Oncotarget; 2014 May; 5(9):2723-35. PubMed ID: 24809298
[TBL] [Abstract][Full Text] [Related]
5. Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel.
ter Braak B; Siezen CL; Kannegieter N; Koedoot E; van de Water B; van der Laan JW
Arch Toxicol; 2014 Apr; 88(4):953-66. PubMed ID: 24464500
[TBL] [Abstract][Full Text] [Related]
6. Controlled dimerization of insulin-like growth factor-1 and insulin receptors reveals shared and distinct activities of holo and hybrid receptors.
Chen J; Nagle AM; Wang YF; Boone DN; Lee AV
J Biol Chem; 2018 Mar; 293(10):3700-3709. PubMed ID: 29330302
[TBL] [Abstract][Full Text] [Related]
7. Targeting Insulin Receptor in Breast Cancer Using Small Engineered Protein Scaffolds.
Chan JY; Hackel BJ; Yee D
Mol Cancer Ther; 2017 Jul; 16(7):1324-1334. PubMed ID: 28468775
[TBL] [Abstract][Full Text] [Related]
8. InsR/IGF1R Pathway Mediates Resistance to EGFR Inhibitors in Glioblastoma.
Ma Y; Tang N; Thompson RC; Mobley BC; Clark SW; Sarkaria JN; Wang J
Clin Cancer Res; 2016 Apr; 22(7):1767-76. PubMed ID: 26561558
[TBL] [Abstract][Full Text] [Related]
9. High expression of insulin receptor on tumour-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survival.
Roudnicky F; Dieterich LC; Poyet C; Buser L; Wild P; Tang D; Camenzind P; Ho CH; Otto VI; Detmar M
J Pathol; 2017 Jun; 242(2):193-205. PubMed ID: 28295307
[TBL] [Abstract][Full Text] [Related]
10. Highly specific role of the insulin receptor in breast cancer progression.
Rostoker R; Abelson S; Bitton-Worms K; Genkin I; Ben-Shmuel S; Dakwar M; Orr ZS; Caspi A; Tzukerman M; LeRoith D
Endocr Relat Cancer; 2015 Apr; 22(2):145-57. PubMed ID: 25694511
[TBL] [Abstract][Full Text] [Related]
11. Loss of E-cadherin Enhances IGF1-IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR Inhibitors.
Nagle AM; Levine KM; Tasdemir N; Scott JA; Burlbaugh K; Kehm J; Katz TA; Boone DN; Jacobsen BM; Atkinson JM; Oesterreich S; Lee AV
Clin Cancer Res; 2018 Oct; 24(20):5165-5177. PubMed ID: 29941485
[No Abstract] [Full Text] [Related]
12. The Role of Nuclear Insulin and IGF1 Receptors in Metabolism and Cancer.
Werner H; Sarfstein R; Laron Z
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33918477
[TBL] [Abstract][Full Text] [Related]
13. ETV6-NTRK3-mediated breast epithelial cell transformation is blocked by targeting the IGF1R signaling pathway.
Tognon CE; Somasiri AM; Evdokimova VE; Trigo G; Uy EE; Melnyk N; Carboni JM; Gottardis MM; Roskelley CD; Pollak M; Sorensen PH
Cancer Res; 2011 Feb; 71(3):1060-70. PubMed ID: 21148487
[TBL] [Abstract][Full Text] [Related]
14. Differential expression and signaling activation of insulin receptor isoforms A and B: A link between breast cancer and diabetes.
Kalla Singh S; Brito C; Tan QW; De León M; De León D
Growth Factors; 2011 Dec; 29(6):278-89. PubMed ID: 21913804
[TBL] [Abstract][Full Text] [Related]
15. Insulin receptor and IGF1R are not required for oocyte growth, differentiation, and maturation in mice.
Pitetti JL; Torre D; Conne B; Papaioannou MD; Cederroth CR; Xuan S; Kahn R; Parada LF; Vassalli JD; Efstratiadis A; Nef S
Sex Dev; 2009; 3(5):264-72. PubMed ID: 19851056
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of RPS6K reveals context-dependent Akt activity in luminal breast cancer cells.
Erdem C; Lee AV; Taylor DL; Lezon TR
PLoS Comput Biol; 2021 Jun; 17(6):e1009125. PubMed ID: 34191793
[TBL] [Abstract][Full Text] [Related]
17. Disruption of insulin receptor function inhibits proliferation in endocrine-resistant breast cancer cells.
Chan JY; LaPara K; Yee D
Oncogene; 2016 Aug; 35(32):4235-43. PubMed ID: 26876199
[TBL] [Abstract][Full Text] [Related]
18. Quantifying insulin receptor isoform expression in FFPE breast tumors.
Harrington SC; Weroha SJ; Reynolds C; Suman VJ; Lingle WL; Haluska P
Growth Horm IGF Res; 2012; 22(3-4):108-15. PubMed ID: 22551578
[TBL] [Abstract][Full Text] [Related]
19. Minireview: nuclear insulin and insulin-like growth factor-1 receptors: a novel paradigm in signal transduction.
Sarfstein R; Werner H
Endocrinology; 2013 May; 154(5):1672-9. PubMed ID: 23507573
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of type-1 insulin-like growth factor receptor signaling through insulin receptor substrate-1 and -2 in pancreatic beta cells.
Xuan S; Szabolcs M; Cinti F; Perincheri S; Accili D; Efstratiadis A
J Biol Chem; 2010 Dec; 285(52):41044-50. PubMed ID: 20947509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]